Form 8-K - Current report:
SEC Accession No. 0001683168-25-000077
Filing Date
2025-01-03
Accepted
2025-01-03 17:00:34
Documents
37
Period of Report
2025-01-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cns_8k.htm   iXBRL 8-K 30249
2 PRESENTATION DATED JANUARY 2025 cns_ex9901.htm EX-99.1 41180
6 GRAPHIC image_049.jpg GRAPHIC 35264
7 GRAPHIC image_050.jpg GRAPHIC 111740
8 GRAPHIC image_051.jpg GRAPHIC 65552
9 GRAPHIC image_052.jpg GRAPHIC 49666
10 GRAPHIC image_053.jpg GRAPHIC 79273
11 GRAPHIC image_054.jpg GRAPHIC 73700
12 GRAPHIC image_055.jpg GRAPHIC 85740
13 GRAPHIC image_056.jpg GRAPHIC 60093
14 GRAPHIC image_057.jpg GRAPHIC 63512
15 GRAPHIC image_058.jpg GRAPHIC 52052
16 GRAPHIC image_059.jpg GRAPHIC 71903
17 GRAPHIC image_060.jpg GRAPHIC 56479
18 GRAPHIC image_061.jpg GRAPHIC 52500
19 GRAPHIC image_062.jpg GRAPHIC 40087
20 GRAPHIC image_063.jpg GRAPHIC 65324
21 GRAPHIC image_064.jpg GRAPHIC 65548
22 GRAPHIC image_065.jpg GRAPHIC 51804
23 GRAPHIC image_066.jpg GRAPHIC 63735
24 GRAPHIC image_067.jpg GRAPHIC 63647
25 GRAPHIC image_068.jpg GRAPHIC 78388
26 GRAPHIC image_069.jpg GRAPHIC 38756
27 GRAPHIC image_070.jpg GRAPHIC 76238
28 GRAPHIC image_071.jpg GRAPHIC 35631
  Complete submission text file 0001683168-25-000077.txt   2238551

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cnsp-20250103.xsd EX-101.SCH 3018
4 XBRL LABEL FILE cnsp-20250103_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cnsp-20250103_pre.xml EX-101.PRE 24167
39 EXTRACTED XBRL INSTANCE DOCUMENT cns_8k_htm.xml XML 3802
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 25507509
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)